Verona Pharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Verona Pharma and other ETFs, options, and stocks.

About VRNA

Verona Pharma Plc operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. Its lead product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound. 

CEO
David S. Zaccardelli
CEODavid S. Zaccardelli
Employees
26
Employees26
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2005
Founded2005
Employees
26
Employees26

VRNA Key Statistics

Market cap
765.82M
Market cap765.82M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
227.63K
Average volume227.63K
High today
$10.68
High today$10.68
Low today
$10.22
Low today$10.22
Open price
$10.50
Open price$10.50
Volume
123.88K
Volume123.88K
52 Week high
$14.69
52 Week high$14.69
52 Week low
$3.41
52 Week low$3.41

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

VRNA Earnings

-$0.48
-$0.27
-$0.05
$0.16
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, Pre-Market
ActualExpected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.